The discrediting of the monoamine hypothesis

Area of Science:

• Neuroscience
• Biochemistry
• Medical Research

Background:

• The monoamine hypothesis, a long-standing theory, posits that imbalances in monoamine neurotransmitters (serotonin, dopamine, norepinephrine) are central to various disease states.
• Organic cation transporters (OCTs) play a crucial role in regulating monoamine concentrations within the central nervous system.

Purpose of the Study:

• To investigate the validity of the monoamine hypothesis by examining the functional status of nutritionally driven organic cation transporters.
• To correlate OCT function with established claims of the monoamine hypothesis regarding disease etiology.

Main Methods:

• Analysis of laboratory assays from subjects without hyperexcreting tumors.
• Assessment of endogenous, day-to-day variations in centrally acting monoamine concentrations.
• Correlation of monoamine levels with disease symptoms and regulatory dysfunction.

Main Results:

• Centrally acting monoamine concentrations were found to be similar in subjects with and without disease symptoms.
• Significant day-to-day variability in monoamine concentrations was observed within the same subjects, rendering baseline testing unreliable.
• These findings indicate that endogenous monoamine levels do not consistently correlate with disease states.

Conclusions:

• The monoamine hypothesis, as a primary explanation for chronic electrical dysfunction linked to monoamines, is not supported by the current findings.
• The "bundle damage theory" is proposed as a more accurate model, suggesting normal but insufficient synaptic monoamine levels in dysfunction states.
• The monoamine hypothesis is relegated to a historical perspective due to its inability to explain chronic neuronal electrical flow dysfunction.